|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7900 EUR | +0.77% |
|
-5.39% | -17.71% |
| 05-22 | Transgene SA Announces Board Appointments | CI |
| 04-13 | Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer | CI |
| Capitalization | 216M 250M 199M 187M 348M 23.81B 353M 2.36B 918M 11.51B 938M 918M 40.04B | P/E ratio 2026 * |
-5.64x | P/E ratio 2027 * | -3.59x |
|---|---|---|---|---|---|
| Enterprise value | 147M 170M 135M 127M 237M 16.19B 240M 1.61B 625M 7.83B 638M 624M 27.23B | EV / Sales 2026 * |
20.4x | EV / Sales 2027 * | 29x |
| Free-Float |
65.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Transgene
| 1 day | +0.77% | ||
| 1 week | -5.39% | ||
| Current month | -5.39% | ||
| 3 months | -3.66% | ||
| 6 months | -13.76% | ||
| Current year | -17.71% |
| 1 week | 0.76 |  | 0.82 |
| 1 month | 0.76 | | 0.86 |
| Current year | 0.73 | | 1.03 |
| 1 year | 0.73 | | 1.5 |
| 3 years | 0.53 | | 2.04 |
| 5 years | 0.53 | | 2.99 |
| 10 years | 0.53 | | 3.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 65 | 31/05/2023 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 26/03/2024 |
Simone Steiner
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Benoît Habert
BRD | Director/Board Member | 61 | 26/07/2010 |
| Director/Board Member | 76 | 18/06/2013 | |
Alain Mérieux
BRD | Director/Board Member | 87 | 31/12/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-01 | Compagnie Merieux Alliance SAS
| Buy | Company | 84,745,400 | 63.8367% | |
| 12-01 | Compagnie Merieux Alliance SAS
| Buy | Company | 38,492,172 | 28.9953% | |
| 01/08/24 | Compagnie Merieux Alliance SAS
| Buy | Company | 30,898,876 | 23.3562% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | -5.39% | -16.49% | -61.08% | 250M | |
| +5.10% | +7.04% | +48.39% | +107.48% | 55.01B | |
| -0.20% | -4.96% | +50.88% | +52.59% | 43.37B | |
| -1.69% | -8.20% | -18.81% | -19.50% | 22.27B | |
| -10.20% | -11.87% | +27.98% | +376.34% | 20.42B | |
| -4.70% | -9.59% | +20.38% | -28.13% | 17.27B | |
| +3.90% | -7.07% | +9.55% | -41.13% | 15.02B | |
| +0.40% | +4.40% | +22.47% | +173.48% | 13.25B | |
| -3.36% | -11.99% | +11.40% | - | 11.71B | |
| -0.47% | -15.79% | -28.27% | +685.64% | 11.46B | |
| Average | -0.94% | -5.67% | +12.75% | +138.41% | 21B | |
| Weighted average by Cap. | -0.10% | -2.94% | +26.75% | +123.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.2M 8.31M 6.61M 6.22M 11.58M 792M 11.76M 78.53M 30.56M 383M 31.22M 30.54M 1.33B | 7.2M 8.31M 6.61M 6.22M 11.58M 792M 11.76M 78.53M 30.56M 383M 31.22M 30.54M 1.33B |
| Net income | -38.2M -44.11M -35.05M -32.98M -61.42M -4.2B -62.38M -417M -162M -2.03B -166M -162M -7.07B | -61.6M -71.13M -56.52M -53.18M -99.05M -6.78B -101M -672M -261M -3.28B -267M -261M -11.4B |
| Net Debt | -69.2M -79.91M -63.5M -59.74M -111M -7.61B -113M -755M -294M -3.68B -300M -294M -12.81B | -7.7M -8.89M -7.07M -6.65M -12.38M -847M -12.57M -83.98M -32.68M -410M -33.39M -32.66M -1.42B |
Employees
145
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/06/26 | 0.7900 € | +0.77% | 21,393 |
| 04/06/26 | 0.7840 € | -1.26% | 67,547 |
| 03/06/26 | 0.7940 € | -1.37% | 40,440 |
| 02/06/26 | 0.8050 € | -1.35% | 25,973 |
| 01/06/26 | 0.8160 € | -2.28% | 67,402 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7900EUR
Average target price
1.100EUR
Spread / Average Target
+39.24%
Annual profits - Rate of surprise
- Stock Market
- Equities
- TNG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition